Vaccinex (VCNX) Stock Highlights

3.71 | +13.8%

2024-11-21 06:36:26

Vaccinex Inc is pioneering a differentiated approach to treating cancer and slowly progressive neurodegenerative diseases through the inhibition of semaphorin 4D (SEMA4D). The companys lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that it believes prevents immune infiltration into tumors and triggers inflammation in chronic diseases of the brain. Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimers Disease, with ongoing exploration of potential Phase 3 development in Huntingtons disease. The firm has also developed a proprietary drug discovery platform, ActivMAb. The firm generates revenue from collaborative research, license, development and commercialization agreements.

Statistics

Range Today

3.28 3.72

Volume Today 29.9K

Range 1 Year

1.39 13.02

Volume 1 Year 12.62M

Range 3 Year

1.39 478.8

Volume 3 Year 16.27M

Range 10 Year

1.39 2568.3

Volume 10 Year 18.75M

Highlights

Market Capitalization 9.22M (micro)

Floating Shares 934.51K

Current Price 3.71

Price To Earnings -0.89

Price To Revenue 18.61

Earnings Per Share -3.72

Payout Ratio 0%

Performance

Latest +13.8%

1 Month +44.92%

3 Months -27.68%

6 Months -32.91%

1 Year -71.51%

3 Years -98.93%

5 Years -99.64%

10 Years -99.85%

Benchmarks

Market Capitalization

343 / 368

Gross Profits

165 / 278

Total Revenue

242 / 300

Total Rank

363 / 368

Free Cashflow

99 / 352

Performance 5 years

363 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.